Mao MJ - Search Results

1

CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.

Chen Y, Tian T, Mao MJ, Deng WY, Li H. Chen Y, et al. Among authors: mao mj. BMC Cancer. 2018 May 2;18(1):514. doi: 10.1186/s12885-018-4249-1. BMC Cancer. 2018. PMID: 29720147 Free PMC article.

2

High level of serum apolipoprotein A-I is a favorable prognostic factor for overall survival in esophageal squamous cell carcinoma.

Wang XP, Li XH, Zhang L, Lin JH, Huang H, Kang T, Mao MJ, Chen H, Zheng X. Wang XP, et al. Among authors: mao mj. BMC Cancer. 2016 Jul 21;16:516. doi: 10.1186/s12885-016-2502-z. BMC Cancer. 2016. PMID: 27444612 Free PMC article.

3

A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma.

Wang XP, Mao MJ, He ZL, Zhang L, Chi PD, Su JR, Dai SQ, Liu WL. Wang XP, et al. Among authors: mao mj. J Cancer. 2017 Jul 5;8(11):2079-2087. doi: 10.7150/jca.19181. eCollection 2017. J Cancer. 2017. PMID: 28819409 Free PMC article.

4

Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.

Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Liu WL. Mao MJ, et al. BMC Cancer. 2018 Jan 2;18(1):9. doi: 10.1186/s12885-017-3718-2. BMC Cancer. 2018. PMID: 29295705 Free PMC article.

5

Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.

Xue N, Lin JH, Xing S, Liu D, Li SB, Lai YZ, Wang XP, Mao MJ, Zhong Q, Zeng MS, Liu WL. Xue N, et al. Among authors: mao mj. Cancer Res Treat. 2019 Jan;51(1):378-390. doi: 10.4143/crt.2018.070. Epub 2018 May 29. Cancer Res Treat. 2019. PMID: 29807404 Free PMC article.

6

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients.

Mao M, Wang X, Sheng H, Liu Y, Zhang L, Dai S, Chi PD. Mao M, et al. BMC Cancer. 2018 Nov 28;18(1):1178. doi: 10.1186/s12885-018-5028-8. BMC Cancer. 2018. PMID: 30486825 Free PMC article.

7

Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer.

Sheng H, Wei X, Mao M, He J, Luo T, Lu S, Zhou L, Huang Z, Yang A. Sheng H, et al. BMC Cancer. 2019 Nov 8;19(1):1071. doi: 10.1186/s12885-019-6245-5. BMC Cancer. 2019. PMID: 31703713 Free PMC article.

8

A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer Patients.

Wang X, Mao M, Zhu S, Xing S, Song Y, Zhang L, Chi P. Wang X, et al. Adv Ther. 2020 Jun;37(6):2902-2915. doi: 10.1007/s12325-020-01356-4. Epub 2020 May 3. Adv Ther. 2020. PMID: 32363466

9

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).

Zhang L, Ye J, Luo Q, Kuang M, Mao M, Dai S, Wang X. Zhang L, et al. Cancer Manag Res. 2020 Jul 3;12:5373-5384. doi: 10.2147/CMAR.S246695. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753955 Free PMC article.

10

Novel prognostic scores based on serum ferritin/globulin ratio in patients with hepatocellular carcinoma.

Liu W, Chen Q, Mao M, Han R, Liu Y, Wang X. Liu W, et al. Transl Cancer Res. 2020 Oct;9(10):5925-5939. doi: 10.21037/tcr-20-966. Transl Cancer Res. 2020. PMID: 35117205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters